Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial.

Xiao-Yang HuTom OliverMerlin WillcoxCatherine SimpsonKerensa ThorneJeanne TrillNick FrancisBeth StuartMichael ThomasPaul LittleJian-Ping LiuGareth GriffithsMichael Moore

Published in: Pilot and feasibility studies (2022)

This trial is registered via ISRCTN on 1 July 2021, identifier: ISRCTN26614726.

Keyphrases

study protocol
placebo controlled
double blind
phase iii
phase ii
clinical trial
chronic obstructive pulmonary disease
randomized controlled trial
open label
liver failure
phase ii study
cystic fibrosis
lung function
respiratory failure
squamous cell carcinoma
drug induced
air pollution
locally advanced